Alisa Rybkin

Honored to host Dr. @BobTimmermanMD for the 2nd annual @RoyHDecker Memorial Lectureship at Yale. A fitting speaker to honor one of SABR's early trailblazers, and a thought-provoking look at the future of ablative radiotherapy. #YaleRadOnc #RadOnc #PULSAR

Proud of our Chief Resident! 👏 Dr. @AlisaRybkin presents her first of two posters at the 2026 ASTRO Multidisciplinary Head & Neck Symposium — a systematic review of patient-reported outcomes with definitive proton therapy in HNSCC. #YaleRadOnc #ASTRO #RadiationOncology

A new @JNCI_Now editorial applauds #DARTBOARD trial showing daily adaptive radiation therapy #DART is feasible, safe for head + neck cancer, and should not be discounted. Future trials should focus on improved pt selection. academic.oup.com/jnci/advance-a… @SmilowCancer #HNSCC @HenryParkMD @RasarYoungMDPhD @AlisaRybkin

.@AlisaRybkin presents a high-impact, low-cost quality improvement initiative at #ASTRO25 aimed at boosting radiation therapy adherence after breast-conserving surgery—highlighting the vital role of patient navigation. @YaleRadOnc @SmilowCancer @ASTRO_org Learn More⬇️ poster.astro.org/astro/2025/67t…

Yale Therapeutic Radiology has made it to #ASTRO25! Excited to learn, collaborate, and showcase our own work in the great city of San Francisco! 🌁

Throughout the day today we have great poster presentations scheduled at #ASTRO25, featuring @ShariBodofsky, @AlisaRybkin, Dr. Victor Lee, and Elaine Yang! #full-schedule" target="_blank" rel="nofollow noopener">amportal.astro.org/sessions?_DATE… @SmilowCancer @YaleRadOnc

In this @JAMAOnc editorial, @AlisaRybkin et al. explain how distant relapse has become the key challenge as #radiotherapy improves locoregional control in locally advanced nasopharyngeal carcinoma #LANPC. Optimizing systemic therapy + ⬇️ toxicity is critical to improve outcomes. jamanetwork.com/journals/jamao… @SmilowCancer @HenryParkMD @AartiBhatiaMD

Congratulations to Xue et al for completing this important trial! While not yet practice-changing, it will contribute to understanding optimal treatment sequencing in an ever-changing landscape in nasopharynx cancer, per our editorial led by @AlisaRybkin. jamanetwork.com/journals/jamao…

Hats off to our graduating chiefs! 🎓👏 Congrats @dg_wallington on your next chapter in private practice in Michigan, and cheers to @PatrickOhMD & @nsmoores for sticking around to help keep Yale RadOnc exceptional! 🏥💙 #YaleRadOnc #ClassOf2025

History, theory, and clinical practice all in one room! 🏛️💥 The first annual #YROC Research Symposium on Friday spotlighted diverse research from Yale #RadOnc’s brilliant faculty and trainees — proof that collaboration fuels innovation! 🧬👩‍🔬

Happy #NationalWomenPhysiciansDay to all of our amazing women physicians who go above and beyond to provide exceptional leadership, education, and care for our patients! #radonc @YaleCancer, @SmilowCancer, @ASTRO_org

Great first @eaonc meeting, not only learning about science & trial design but also catching up with friends ☢️😃 @A_CT_SimMDJD @gainesmdphd @AlisaRybkin @ARRO_org

We were incredibly honored to host @BK_radiation to give the inaugural Roy Decker Memorial Lectureship. Thank you, Dr. Kavanagh, for joining us in celebrating Dr. Decker’s legacy and the lasting impact he made on each of our lives!

Catching some rays for picture day with this beaming resident squad! @YaleCancer @SmilowCancer

That’s a wrap on our trip to #ASTRO24! We had a fantastic time presenting our work, celebrating lifelong achievements, and even catching a glimpse of space!

Come join us tomorrow evening at 8PM ET to learn more about us! Register in the link below. There may be guest appearances from a few of our furry friends! 🐶🐺🐕

Always a full house when hosting @DrRoyHerbstYale for grand rounds to hear about the exciting progress being made in the treatment of NSCLC over the past two decades! @SmilowCancer @YaleCancer

G’day to medical education! Honored to host @DrDavidKok as a visiting professor from @PeterMacCC in Melbourne! We enjoyed the thought-provoking discussions about innovative methods in RadOnc learning including the use of VR and AI!

Congratulations to our fantastic team of dosimetrists, physicists, therapists, nurses, residents, and hospital leaders for successfully becoming the world's 5th center to treat lung and bone tumors with biology-guided radiotherapy! @YaleRadOnc @YaleCancer @YaleMed @reflexionmed

Welcome to the fam!